More on treatment of Covid.
First with Dexamethasone.What wasn't said was that if given to patients that didn't need oxygen therapy the trend was to an increased mortality rate.
View attachment 221010.
And since then there is a worry that supply might not keep up to demand especially with the injectable formulation which is necessary for the most severe cases being ventilated.And this is the group with the best results.
www.sciencemag.org
Back to hydroxychloroquine.note that image above also gives the result of their trial with this drug which ended the hydroxychloroquine story.but the increase in mortality first of all didn't reach statistical significance.but more importantly was the dosage of hydroxychloroquine used.2400mg in the first 24 hours.This is a massively toxic dose and 6 times the recommended dose to avoid cardiac toxicity.some medical commentators are now using the word negligence.
But a new drug-one of the biologicals.
Inhibiting granulocyte–macrophage colony-stimulating factor (GM-CSF) signalling may offer a therapeutic benefit in patients suffering from severe coronavirus disease 2019 (COVID-19) pneumonia and systemic hyperinflammation, according to a study published in The Lancet Rheumatology.Preliminary...
dgalerts.docguide.com